487 filings
Page 9 of 25
6-K
mo8 ptvxm
13 Apr 21
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
7:45am
6-K
ozz6qpw0 vsa
31 Mar 21
Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results
8:27am
6-K
abxp9tb
12 Mar 21
Report of Foreign Private Issuer
8:56am
SC 13G/A
0cjnxhao gnvlgg
12 Feb 21
Auris Medical Holding / Altium Capital Management ownership change
5:15pm
6-K
mwhmdgoj4 lp10
15 Jan 21
Report of Foreign Private Issuer
4:38pm
424B5
ow7zghc2ti
15 Jan 21
Prospectus supplement for primary offering
4:32pm
S-8
y5j5fjolu6wvfvaglh
15 Jan 21
Registration of securities for employees
4:05pm
6-K
c48kpx
10 Dec 20
Report of Foreign Private Issuer
8:01am
SC 13D/A
sfyaau12079594
7 Dec 20
Auris Medical Holding / Meyer Thomas ownership change
3:49pm
6-K
t65bi
3 Dec 20
Auris Medical Holding LTD. Prices $8,000,000 Common Shares Offering Priced At-the-market
5:26pm
424B5
3s06up8jk2y07xdf19z
3 Dec 20
Prospectus supplement for primary offering
5:25pm
6-K
sanuhjwtnt ig9ao1
2 Dec 20
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
7:01am
424B3
bmwl1ok8
16 Nov 20
Prospectus supplement
5:05pm
424B3
7r4bik4mgq 13
16 Nov 20
Prospectus supplement
5:00pm
EFFECT
m2cjzc8
2 Nov 20
Notice of effectiveness
12:20am
CORRESP
t98tol7r zcue1wdi6r
21 Oct 20
Correspondence with SEC
12:00am
6-K
6ni5vrq98jac9y l34m
9 Oct 20
Report of Foreign Private Issuer
4:30pm
UPLOAD
ic0 f5nbf
9 Oct 20
Letter from SEC
12:00am
F-3
jmwc aes6xiksy
6 Oct 20
Shelf registration (foreign)
5:02pm